Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Jan 9;8:151. doi: 10.1038/s41598-017-18532-2

Surveillance of vector-borne pathogens under imperfect detection: lessons from Chagas disease risk (mis)measurement

Thaís Tâmara Castro Minuzzi-Souza 1, Nadjar Nitz 2, César Augusto Cuba Cuba 1, Luciana Hagström 2, Mariana Machado Hecht 2, Camila Santana 2, Marcelle Ribeiro 2, Tamires Emanuele Vital 2, Marcelo Santalucia 3, Monique Knox 4, Marcos Takashi Obara 1, Fernando Abad-Franch 5,✉,#, Rodrigo Gurgel-Gonçalves 1,✉,#
PMCID: PMC5760667  PMID: 29317702

Abstract

Vector-borne pathogens threaten human health worldwide. Despite their critical role in disease prevention, routine surveillance systems often rely on low-complexity pathogen detection tests of uncertain accuracy. In Chagas disease surveillance, optical microscopy (OM) is routinely used for detecting Trypanosoma cruzi in its vectors. Here, we use replicate T. cruzi detection data and hierarchical site-occupancy models to assess the reliability of OM-based T. cruzi surveillance while explicitly accounting for false-negative and false-positive results. We investigated 841 triatomines with OM slides (1194 fresh, 1192 Giemsa-stained) plus conventional (cPCR, 841 assays) and quantitative PCR (qPCR, 1682 assays). Detections were considered unambiguous only when parasitologists unmistakably identified T. cruzi in Giemsa-stained slides. qPCR was >99% sensitive and specific, whereas cPCR was ~100% specific but only ~55% sensitive. In routine surveillance, examination of a single OM slide per vector missed ~50–75% of infections and wrongly scored as infected ~7% of the bugs. qPCR-based and model-based infection frequency estimates were nearly three times higher, on average, than OM-based indices. We conclude that the risk of vector-borne Chagas disease may be substantially higher than routine surveillance data suggest. The hierarchical modelling approach we illustrate can help enhance vector-borne disease surveillance systems when pathogen detection is imperfect.

Introduction

Vector-borne infectious diseases rank among the most relevant threats to public health globally1. Surveillance of pathogen presence in vectors allows epidemiologists to track variations of disease transmission risk in time and space. This, in turn, is crucial for the design, management, and evaluation of strategies for disease prevention25. To correctly interpret surveillance data, however, health officials need to understand how the tests used to ascertain vector infection actually perform. In particular, they need reliable estimates of each test’s sensitivity and specificity6,7. Sensitivity is defined in this context as the probability that the target pathogen is detected by a test, conditional on the vector being infected. Specificity is the probability that the pathogen is not detected by the test, conditional on the vector being uninfected. These two quantities are usually unknown and <100% for any given test or method – including, arguably, the best-studied diagnostic tests, whose nominal sensitivity and specificity are worked out under extremely artificial conditions that may be hard to replicate in field laboratories8,9.

Many tests are available for detecting pathogens in their hosts and vectors. They range from direct examination of samples under the microscope to sophisticated molecular assays that can detect minute amounts of the pathogen’s genetic material in tissue extracts6,810. The performance of these tests may vary substantially. This mainly depends on the balance between sensitivity and specificity – which as a rule trade-off against one another. Tests that have both high sensitivity and high specificity tend to be more costly, and often require higher-level skills, than simpler, yet not so well-performing, alternatives8,10. This is probably why many routine surveillance systems, particularly in developing countries, rely on low-complexity pathogen detection tests with suboptimal performance – they may be just the affordable and technically viable options11,12. Yet a suboptimal test will yield inaccurate data, and this measurement error can ultimately mislead decision makers8,11. In these cases, knowledge about test performance will provide particularly crucial insight into the performance of routine surveillance, thus widening the scope for sounder public health decision making. Still, widespread uncertainty about the true accuracy of pathogen detection tests in real-life surveillance settings substantially complicates any such assessment.

Here, we illustrate how a hierarchical modelling approach can help assess the performance of vector-borne disease surveillance in the face of imperfect pathogen detection. As a case-study, we investigate the detection of a major human parasite, Trypanosoma cruzi, in its insect vectors13. T. cruzi causes Chagas disease, one of the most important vector-borne diseases in the Americas14. The parasite is primarily transmitted by blood-sucking bugs known as triatomines, and entomological-parasitological routine surveillance (EPRS hereafter) is therefore a key component of Chagas disease control programs1316. In most such programs, trained technicians identify suspect insects collected inside or around houses and check them for T. cruzi infection through optical microscopy (OM) of hindgut contents. OM-based detection of T. cruzi, however, is unlikely to be 100% sensitive or 100% specific1723. T. cruzi surveillance data, then, likely contain a certain, yet largely unknown, amount of measurement error. To quantify this error, we applied multiple detection tests, from routine-surveillance OM to DNA-based methods, to over 800 field-caught vectors. We then used multiple detection-state site-occupancy models24 (a class of hierarchical models) to obtain statistical estimates of each test’s sensitivity and specificity while explicitly accounting for false-negative and false-positive results. These models require (i) replicate testing of a subset of the vectors and (ii) unambiguous identification of a subset of the infections (see Fig. 1 and ref.24). This strategy allowed us to compute corrected estimates of infection frequency in the five triatomine bug species most often found inside and around houses in central Brazil.

Figure 1.

Figure 1

Detecting Trypanosoma cruzi in field-caught vectors. The figure illustrates our strategy of repeatedly checking for infection using (i) optical microscopy (OM) including slides read in routine surveillance (fresh, FS; Giemsa-stained, SS) or at the University of Brasília (fresh, FU; Giemsa-stained, SU), (ii) a conventional PCR (cPCR), and (ii) a replicate quantitative PCR (qPCR R1 and R2). Blank ‘slides’ represent OM slides that were not prepared for a given bug (coded ‘−’); in grey, tests that were scored as negative with ambiguity (possible false negatives, coded ‘0’); in light blue, dark blue, orange, light green, and dark green, tests scored as positive with ambiguity (possible false positives, coded ‘1’); and, in dark red with a parasite, a slide scored as positive without ambiguity (only when a professional parasitologists of the University of Brasília unmistakably identified T. cruzi trypomastigotes in a Giemsa-stained slide, coded ‘2’). The last column shows, for each bug, the “detection history” we used to construct our database, using the codes (‘−’, ‘0’, ‘1’, and ‘2’) defined above. Of the four bugs in this example, only the first one was scored as positive without ambiguity (hence its darker colour); the three light-coloured bugs might or might not have been infected: for the third and fourth, there were some ambiguous detections; for the last one, the six non-detections could have arisen either because the bug was not infected or because the tests failed to detect the parasite.

Results

Naïve infection indices

We investigated T. cruzi detection in 841 triatomine bugs of five species collected inside or around houses in the state of Goiás and the Federal District, Brazil. We used different combinations of OM slide readings (fresh and/or Giemsa-stained slides read in EPRS and/or at the University of Brasília [UnB]) and conventional plus real-time quantitative PCRs (cPCR and qPCR, respectively) (see Tables 1 and 2 and Methods). Overall, 397 bugs were scored as positive in at least one test, for a naïve infection index of 47.2%. Note, however, that this calculation relies on the assumption that the joint results of the tests applied to each bug ensure 100% sensitivity and 100% specificity. Test-specific naïve indices varied about two-fold, from 17.8% considering OM results only to 41.5% considering PCR results only – with 23.1% positive by cPCR and 41.3–41.4% by qPCR. Considering EPRS results only, infection with T. cruzi was reported in 15.1% of the bugs (from 0% to 27.2%, depending on species; Table 2, Fig. 2). As above, however, the direct interpretation of test-specific naïve values hinges on the assumption that each test, including OM-based detection of T. cruzi in EPRS, is 100% sensitive and 100% specific. Further descriptive details are presented in Tables 1 and 2 and in Fig. 2; the raw data are available in Supplementary Data S1, and PCR protocols in Supplementary Text S1.

Table 1.

Optical microscopy (OM) slides examined to detect Trypanosoma cruzi infection in 841 triatomine bugs, central Brazil, 2012–2014. Fresh and Giemsa-stained slides were examined by entomological-parasitological routine surveillance (EPRS) and University of Brasília (UnB) staff in different combinations.

OM slide combinations Fresh slides Stained slides Bugs1
EPRS UnB EPRS UnB
Fresh EPRS + Fresh UnB 19
Fresh EPRS + Stained EPRS 29
Fresh EPRS + Stained UnB 67
Fresh UnB + Stained UnB 22
Fresh EPRS + Fresh UnB + Stained UnB 334
Fresh EPRS + Stained EPRS + Stained UnB 370
Total (slides/bugs) 819 375 399 793 (2386/841)

1All tested also by one conventional and two real-time quantitative PCRs. •Slide read.

Table 2.

Numbers of triatomine bugs tested and scored as positive for Trypanosoma cruzi infection by optical microscopy and molecular methods.

Test Triatomine bug species
P. megistus T. sordida R. neglectus T. pseudomaculata P. geniculatus
n + n + n + n + n +
Fresh slide EPRS 405 38 273 55 92 24 33 0 16 1
UnB 332 41 0 1 0 40 0 2 0
Stained slide EPRS 21 3 273 60 91 25 0 14 0
UnB 395 41(12) 248 28(26) 89 16(16) 45 0(0) 16 0(0)
Microscopy1 EPRS 405 38 273 60 92 25 33 0 16 1
UnB 414 42 248 28 89 16 45 0 16 0
Total 415 64 273 60 92 25 45 0 16 1
cPCR 415 84 273 63 92 22 45 24 16 2
qPCR 1st 415 184 273 89 92 41 45 30 16 3
2nd 415 186 273 88 92 41 45 30 16 3
Molecular1 Total 415 186 273 89 92 41 45 30 16 3
Total1 415 215 273 100 92 48 45 30 16 4

P., Panstrongylus; T., Triatoma; R., Rhodnius. EPRS, entomological-parasitological routine surveillance systems (state of Goiás and Federal District, Brazil); UnB, University of Brasília; cPCR, conventional PCR on the 24Sα subunit of the nuclear ribosomal DNA; qPCR, real-time PCR on nuclear satellite DNA For each species, the numbers of bugs tested (n) and scored as positive (+) are given; for Giemsa-stained microscope slides read at UnB, the number of bugs in which infection was unambiguously determined is also given (in parentheses). 1Bugs scored as positive in at least one test.

Figure 2.

Figure 2

Trypanosoma cruzi infection in 841 triatomine bugs caught inside or around houses of central Brazil, 2012–2014. Bars represent the observed proportions of bugs scored as positive with different methods, and circles show infection probabilities as estimated by the focal site-occupancy model. EPRS, entomological-parasitological routine surveillance; UnB, University of Brasília; cPCR rDNA-24Sα, conventional PCR on the 24Sα subunit of the nuclear ribosomal DNA; qPCR nDNA-sat, quantitative PCR on the nuclear satellite DNA; CI, confidence interval; arrowheads indicate instances in which no bug was tested by a given method (see Table 2).

Hierarchical modelling

A site-occupancy model with bug species-specific infection probability and test-specific sensitivity and specificity (i.e., our focal model; see Methods) had a second-order Akaike’s Information Criterion (AICc) score25 from 18.5 to >1020 units smaller than models in which those parameters were held constant across, respectively, bug species and pathogen detection tests. These simpler models, hence, had no support from the data25, and we therefore base inference on our focal model. Figures 2 and 3 present, respectively, the estimates of species-specific infection frequency and of test-specific sensitivity and specificity computed using this model; the values of back-transformed estimates and 95% confidence intervals (CIs) are presented in Supplementary Table S1.

Figure 3.

Figure 3

Performance of microscopy and PCR for the Trypanosoma cruzi detection in insect vectors: sensitivity and specificity as estimated through site-occupancy modelling. EPRS, entomological-parasitological routine surveillance; UnB, University of Brasília; cPCR rDNA-24Sα, conventional PCR on the 24Sα subunit of the nuclear ribosomal DNA; qPCR nDNA-sat, quantitative PCR on the nuclear satellite DNA; CI, 95% confidence interval (an asterisk indicates that the CI could not be estimated for cPCR specificity).

Test sensitivity and specificity

Our focal model suggests that sensitivity varies considerably, and specificity moderately, among tests (Fig. 3). The estimated sensitivity of OM-based tests was overall low, both in EPRS (fresh slide, 24.5%, CI 20.2–29.5%; stained slide, 50.7%, CI 42.4–59.0%) and at the UnB (fresh slide, 14.3%, CI 10.2–19.9%; stained slide, 22.6%, CI 18.3–27.6%). cPCR had low sensitivity (56.0%, CI 50.7–61.1%, comparable to that of Giemsa-stained OM slides read in EPRS), whereas qPCR had very high sensitivity (99.7%), with a lower CI limit just above 98% and an upper limit at 99.9% (Fig. 3 and Supplementary Table S1). Specificity was always estimated at > 90%, although 95% CIs overlapped that value for OM-based tests applied in EPRS (fresh slide, 92.6%, CI 89.8–94.6%; stained slide, 92.8%, CI 89.0–95.4%) and for fresh slides read at UnB (93.1%, CI 88.2–96.0%; stained slide, 97.1%, CI 95.1–98.3%). The estimate for cPCR specificity was virtually 1.0, with a large standard error suggesting that the maximum-likelihood solution lies close to the boundary. qPCR again performed very well, with an estimated specificity close to 100% and a lower CI limit of 95.0% (see Fig. 3 and Supplementary Table S1).

Frequency of infection in vectors

Along with the test performance estimates given above, our focal model yielded a corrected estimate of the frequency of T. cruzi infection (denoted Ψ) in each of the five vector species in our sample. As Fig. 2 and Table 2 and Supplementary Table S1 show, Ψ estimates were very close to naïve indices computed from qPCR data – which reflects the excellent performance of this test. Importantly, model-based infection estimates were consistently larger (about two times, from 1.3 to 3.0) than naïve indices computed from OM or cPCR (Fig. 2). Species-specific EPRS-based indices and model-based Ψ values compared as follows: Panstrongylus megistus 9.4% vs. 44.7%; Triatoma sordida 22.0% vs. 32.6%; Rhodnius neglectus 27.2% vs. 44.6%; Triatoma pseudomaculata 0% vs. 66.7%; and Panstrongylus geniculatus 6.3% vs. 18.8% (Fig. 2, Table 2). Model-based estimates were somewhat smaller than indices based on the combined results from all tests, reflecting the fact that OM-based tests likely yielded some false-positive results. Finally, the size of CIs around model-based Ψ estimates clearly highlights our uncertainty about infection probabilities when sample sizes are small – particularly for P. geniculatus (n = 16) but also, albeit to a lesser extent, for T. pseudomaculata (n = 45) and R. neglectus (n = 92) (see Fig. 2 and Supplementary Table S1).

Discussion

In this study we have demonstrated the use of a hierarchical modelling approach24 to investigate the performance of routine surveillance in the context of a major vector-borne parasitic disease. The results show that detecting T. cruzi in its triatomine bug vectors can be difficult. The estimated sensitivity of OM-based tests was below 30% except for Giemsa-stained slides examined in EPRS – which, in any case, failed to detect about half of the infections (Figs 2 and 3). As a consequence, naïve indices based on EPRS data consistently underestimated the true frequency of T. cruzi infection in vectors caught inside or around houses in central Brazil. In our hands, cPCR of ribosomal DNA had low sensitivity (barely above 55%) but very high specificity (Fig. 3). The sensitivity and specificity of the more sophisticated qPCR of nuclear satellite DNA were both >99%; this, therefore, was the only test yielding nearly unbiased infection indices (Figs 2 and 3, Supplementary Table S1).

It is not surprising that detecting microscopic protozoa is a difficult task. Less widely realised, however, is the fact that imperfect detection can affect any organism including plants, insects, and up to large-sized mammals2630. It also affects molecules, including antibodies or DNA3133. The consequences of imperfect detection can be particularly problematic when the target organism is a human pathogen. In the clinical setting, efforts have concentrated on the development of better-performing diagnostic tests, but this usually implies higher costs and/or a need for more sophisticated equipment and skills. In disease surveillance, where large numbers of samples are often processed, such high-cost, high-technology tests are usually impractical. This is particularly evident in developing countries, where decentralised surveillance laboratories often lack the resources needed to use complex tests in routine practice. It should generally be feasible, however, to blindly re-examine a subset of samples with high-performance tests, such as qPCR, in central reference laboratories; these data could then be used to gauge the reliability of imperfect routine tests in an analytical framework similar to that described here23,24,31,3436. This would be a fairly straightforward way to enhance disease surveillance when pathogen detection is imperfect. If, for example, a random subset of just 96 bugs from our sample were tested using just one high-performance qPCR assay (99% sensitive and 100% specific), mean EPRS slide-reading sensitivity would be estimated at 71.4% (CI 63.2–78.4) and specificity at 99.7% (CI 98.4–99.9). Despite a modest, yet evident, upward bias, these estimates may be seen as a potentially important improvement (particularly regarding sensitivity) over the typical stance of ignoring the problem by assuming that detection is always perfect (see Text S2).

It should be noted that in some Chagas disease EPRS systems each bug is examined twice – one with a fresh slide and one with a Giemsa-stained slide. According to the estimates from our focal, top-ranking model, and assuming independence, the joint sensitivity of a two-slide test would be Se joint = 1 − (1 − Se fresh) × (1 − Se stained) = 1 − (1–0.245) × (1–0.507) = 0.628, and the joint specificity Sp joint = 1 − (1 − (Sp fresh × Sp stained)) = 0.859 (see Supplementary Table S1 for estimate values). This suggests that, on average, such a two-slide–reading tactic would miss about 37% of infections and would mistakenly score as positive about 14% of the bugs. Albeit somewhat disappointing, these figures do not look entirely hopeless; they suggest that increasing slide-reading sensitivity might be worth the effort: if, for example, the very low sensitivity of fresh-slide reading could be raised to about 50%, then joint sensitivity would be ~75% and only ~25% of infections would be missed. This could perhaps be achieved by simply increasing the number of fresh-slide fields examined in EPRS.

Once reliable estimates of test sensitivity and specificity have been obtained, one can use Bayes’ theorem to calculate posterior probabilities of infection (or non-infection), given test results37. The posterior probability of infection, given the bug was scored as positive in a test, is also known as the positive predictive value of that test, and the posterior probability of non-infection, given a negative test result, as the negative predictive value7. These values depend not only on test performance, but also on the true prevalence of infection in the population the specimen was drawn from7,37. Using test performance estimates from our focal model (including joint performance of two OM slides read in EPRS as given above), and assuming each bug was randomly sampled from the population it belonged to, we calculated the positive and negative predictive values of each test at prior prevalence ranging from 0 to 100%. Figure 4 shows the obviously better performance of qPCR relative to all other tests; although cPCR also yields very good positive predictive values, a negative result is not very reliable as an indicator of absence of infection – except, as with the other tests, when the prevalence in the population is very low (Fig. 4). The graph also highlights the relatively poor performance of OM tests as used in EPRS (Fig. 4).

Figure 4.

Figure 4

Posterior probabilities of vector infection (or non-infection) with Trypanosoma cruzi, given test results: positive and negative predictive values. EPRS, entomological-parasitological routine surveillance; UnB, University of Brasília; cPCR, conventional PCR on the 24Sα subunit of the nuclear ribosomal DNA; qPCR, quantitative PCR on the nuclear satellite DNA. Note that positive predictive values of cPCR (black line) and qPCR (green broken line) largely overlap.

A reliable surveillance system for any vector-borne infection, including Chagas disease, has two main components. Entomological-parasitological surveillance aims at providing data on how often the vectors, and in particular infected vectors, are found in close proximity to humans25,14,15. Epidemiological surveillance aims at detecting human disease cases – and, in particular, new cases, which provide insight on incidence3,4,38. Here we have shown that EPRS data are likely to substantially underestimate natural T. cruzi infection in Chagas disease vectors. We know, in addition, that detecting infestation by those vectors can also be difficult, with sensitivity estimates often below 50%27,28,39. Finally, Chagas disease patients typically present with few signs and symptoms, if any, in the acute phase of infection, and it is estimated that less than 5% of new cases are diagnosed14. Chagas disease routine surveillance data therefore contain three types of (downward) measurement error – infestation by triatomines, vector infection, and human disease all are almost surely more frequent than reported39. This suggests that the risk of Chagas disease transmission to humans is almost surely higher than what crude surveillance data would seem to imply. If unaccounted for when interpreting such data, this composite error can generate a false sense of security that may ultimately mislead expert advisors and decision makers into, respectively, the wrong advice and the wrong decisions39.

Our results come with some important caveats; most of them relate to model assumptions, as outlined in the Methods section. We caution, in particular, that the conditional independence assumption common to most diagnostic test evaluations (e.g., those based on standard latent class analysis23,34,40,41) may not fully hold in our data. This means that our estimates of test performance metrics may be somewhat optimistic, which would lead to some bias in infection frequency estimates – likely a downward bias for the higher estimates and an upward bias for the lower estimates40. Our approach, on the other hand, let us relax the assumption of perfect detection and hence circumvent the need for internal amplification controls in PCR assays – whose absence is a widespread, major limitation of studies that assume perfect detection42. We also stress that OM examination of fresh slides is seldom meant to identify T. cruzi parasites; instead, the examiner usually records the detection of motile microorganisms and labels them as ‘trypanosomatids’. This is typically regarded as an initial, supposedly more sensitive test whose results need to be confirmed by the supposedly more specific examination of a stained slide14. In a sense, then, our estimates of fresh-slide specificity are somewhat ‘unfair’. We found, however, very small differences in specificity for fresh and stained slides (Fig. 3), suggesting that a similar, small fraction of fresh and stained slides scored as positive did not contain viable T. cruzi parasites. Further analyses (OM- and PCR-based) at UnB revealed Trypanosoma rangeli in seven and Blastocrithidia triatomae in 85 of the bugs in our sample43; these results will be presented elsewhere. Finally, we note that we formally considered only a few among the many potential sources of heterogeneity in test performance. In particular for OM, the skills of staff preparing and reading slides, their adherence to written protocols, the quality of reagents and microscopes, or bug-specific parasite loads may all vary and have an effect on performance. We did not have the means to measure or model all these plausible candidate predictors; instead, we present average test performance estimates for what may be considered typical circumstances of EPRS.

In summary, we have demonstrated how hierarchical site-occupancy models can help us develop a more realistic understanding of the performance of T. cruzi detection tests – from the OM-based methods widely used in routine surveillance to sophisticated molecular assays. This quantitative knowledge about test performance allowed us to compute corrected estimates of the frequency of T. cruzi infection in the five vector species most often found in houses across central Brazil. Our analyses revealed a considerable downward bias in T. cruzi infection indices generated by routine surveillance; since vector occurrence indices are also probably biased low, we conclude that the frequency at which infected triatomines occur inside or around houses, and hence the risk of Chagas disease transmission, may be substantially higher than surveillance data suggest. It is rather likely that similar biases affect routine surveillance systems aimed at other pathogens and other vectors. Any such bias must be singled out, quantified, and explicitly taken into account if we are to draw sound, epidemiologically meaningful conclusions from imperfect surveillance data.

Methods

The bugs

From August 2012 to December 2014, the parasitology laboratory at UnB received 841 triatomine bugs caught inside or around houses during EPRS in Goiás and the Federal District of Brazil. All bugs were identified to species at UnB using the keys by Lent & Wygodzinsky13.

Optical microscopy

EPRS staff checked 420 bugs for T. cruzi infection with one fresh OM slide only and 399 bugs with two slides – one fresh and one Giemsa-stained (see below). The results of each OM examination carried out in EPRS, as well as stained slides, were sent together with the bugs to the UnB, where we examined 456 bugs with one OM slide only (19 fresh only, 437 stained only) and 356 bugs with two OM slides (one fresh, one stained). At the UnB, each slide was read for up to 5 minutes; if slim trypomastigotes with a large, round, subterminal kinetoplast44,45 were seen in a slide, then it was scored as unambiguously positive (see below) and the examination stopped. Table 1 shows the number of bugs examined with different combinations of OM slides both in EPRS and at UnB. Each fresh slide was prepared by homogenizing one droplet of bug hindgut contents (faeces and possibly urine) in one drop (~50 μL) of buffered saline solution on a microscope slide and covering it with a cover slip; the slide was examined under a light microscope at 400× magnification17,22,44. For Giemsa staining, thin smears of hindgut contents homogenised in saline solution were fixed with methanol and stained with a buffered 10% Giemsa stain solution; these slides were examined at 1000× magnification44,45. Fresh slides were scored as positive whenever motile forms suggestive of T. cruzi infection were observed; fresh slide scoring was always considered ambiguous. Stained slides were scored as unambiguously positive only when parasites were unmistakably identified as T. cruzi by UnB researchers; in all other cases, the results were considered ambiguous (see Identifying and coding ambiguity below).

DNA-based methods

We stored all bugs at −20 °C at UnB. The bugs were thawed and dissected on sterilised glass slides in a laminar flow safety cabinet. The hindgut was removed with watchmaker forceps and stored in sterile phosphate-buffered saline at −20 °C until DNA extraction. The forceps were thoroughly washed twice (with HCl 0.1 M and with 70% ethanol) and flamed before re-use. DNA was extracted with the Illustra Tissue and Cells Genomic kit (GE Healthcare, Piscataway, NJ), the QIAamp DNA Mini Kit (Qiagen, Valencia, CA), or the Biopur Mini Spin Plus kit (Biometrix, Curitiba, Brazil) according to each manufacturer’s instructions. DNA was quantified with a NanoVue Plus spectrophotometer (GE). We used the QIAamp DNA Mini Kit to extract DNA from (i) one T. cruzi culture (Berenice strain, 5 × 105 epimastigotes/mL) as the positive control and (ii) the hindguts of laboratory-reared, uninfected triatomines (Dipetalogaster maxima) as the negative control. Positive, negative, and blank controls (with no DNA) were included in each PCR round. To ensure that all DNA extracts from bug hindguts contained good-quality DNA, we PCR-amplified ~414 bp of the bugs’ mitochondrial cytochrome b gene46, including blank controls in each PCR run (Supplementary Text S1). Each bug was tested for T. cruzi DNA using two different PCRs. First, we ran a cPCR that targets the variable D7 domain of the 24Sα gene of the nuclear ribosomal DNA47. A bug was scored as cPCR-positive (with ambiguity; see below) when the assay yielded a 270–290-bp band47. Second, we ran a qPCR targeting the nuclear repetitive satellite region of T. cruzi 48 and using SYBR Green technology49. For each bug, we ran two independent qPCR assays. To score detection/non-detection of the parasite’s DNA by qPCR, we built a standard curve50 with serial dilutions of T. cruzi DNA extracted from an epimastigote culture (see above) and ranging from 10−1 to 104 parasite equivalents/mL. As per standard curve results, a bug was scored as qPCR-positive (with ambiguity; see below) when the assay yielded a signal corresponding to ≥ 0.1 parasites/mL (see Supplementary Text S1). We note that all samples contained good-quality DNA (as indicated by amplification of the ~414-bp cytochrome b fragment) and all positive, negative, and blank controls yielded the expected results.

Modelling

To assess how different tests, including those used in EPRS, perform at detecting T. cruzi infection in triatomine bugs, we used the hierarchical modelling approach developed by Miller et al.24. These ‘multiple detection-state site-occupancy models’ explicitly accommodate both false-negative and false-positive results. The models make use of repeated detection/non-detection data (possibly with missing results) to compute maximum-likelihood estimates of (i) the probability that an organism (here, T. cruzi) is detected in a sampling unit where it actually occurs (here, a T. cruzi-infected bug), and (ii) the probability that the organism is detected in a sampling unit where, in reality, it does not occur, i.e., the false-positive error rate24. With this information, the latent, unobserved probability of each sampling unit being ‘occupied’ by the target organism (here, probability of infection) is also estimated24. These probabilities can in addition be modelled as a function of covariates in a generalised linear modelling framework24. The models require that at least a subset of sampling units is checked for the presence of the target organism more than once, and that a subset of the detections can be considered unambiguous24. Below we give details on the modelling approach, which we implemented in Presence 11.8 (ref.51).

Identifying and coding ambiguity

We considered detection of T. cruzi as unambiguous (coded ‘2’) only when T. cruzi parasites with normal morphology (slim trypomastigotes with a large, round, subterminal kinetoplast – which were judged viable) were unmistakably identified in Giemsa-stained OM slides examined at UnB45,5254. For the rest of tests and trials, all detections and non-detections were considered ambiguous and coded ‘1’ and ‘0’, respectively. We thus explicitly acknowledge the possibility that some positive results may be false positives and some negative results false negatives24. Microscope slide examination often yields false-negative results1723. False positives may occur because T. cruzi and other triatomine-infecting trypanosomatids, such as Blastocrithidia spp. or T. rangeli, can be mistaken for one another, especially in fresh OM slides52,54. In the case of PCRs, cross-amplification of heterospecific genomic targets may produce false-positive detections. In addition, a sample containing T. cruzi DNA but no viable parasites may yield a positive, yet epidemiologically irrelevant, PCR result. Cross-sample spillover of amplicons (i.e., contamination), another source of false-positive PCRs, is routinely minimised with appropriate protocols for handling samples and can be detected using negative controls. Finally, polymerase inhibition or variation in primer-binding sequences may yield false-negative PCR results. To account for this pervasive potential for ambiguity, when specifying our models we fixed at 0 the probability (denoted b) that a detection event was classified as unambiguous, given the bug was infected and a detection occurred, for all tests except stained OM slides read at UnB – for which b was estimated.

Defining outcomes and modelling effects

We defined sensitivity (denoted Se) as the probability of detecting viable T. cruzi parasites, conditioned on their occurrence, in a given bug sample. We let Se vary as a function of detection test. Each test was also allowed to have its own probability of false-positive detections, denoted P false (with 1 − P false estimating the specificity Sp of each test). As noted above, b values were only estimated for stained OM slides read at UnB. In our research setting, ‘site-occupancy’ corresponds to the frequency of T. cruzi infection in vectors – the probability Ψ that a bug is ‘occupied by’ (i.e., infected with) viable T. cruzi parasites. To get species-specific estimates of this probability, we let Ψ vary among triatomine bug species. We then computed maximum-likelihood estimates of the parameters and effects of interest (and their variances) using Miller et al.’s24 models and Presence 11.851. We compared our focal model (estimating test-specific Se and Sp and species-specific Ψ) with simpler models assuming constant Ψ across triatomine species or constant Se and Sp across tests. We used Akaike’s Information Criterion scores corrected for finite sample size (AICc, with N = 841) to evaluate relative model performance25.

Model assumptions

As in previous applications of the site-occupancy approach24,3133,35,36 and other forms of latent class analysis23,34, our models assume conditional independence of diagnostic test results. This means that, conditional on the true infection status of a bug, whether one test yields the right (or wrong) result does not affect the probability that another test will also yield the right (or wrong) result40. If there is positive covariance between test results, then false-positive and false-negative error rate estimates will be too low and sensitivity and specificity will be overestimated; infection frequency estimates might also be somewhat biased high for bug species with lower infection frequency and somewhat biased low for bug species with higher infection frequency40. The models also assume independence of individual bugs in relation to infection status, equal test performance across bug species, and that the infection status of the bugs does not change between OM and DNA extraction24. Because we apply multiple tests with two distinct biological underpinnings to a large sample of bugs in several species, we believe that our estimates are unlikely to be badly biased and their confidence intervals unlikely to be exceedingly narrow. We stress, however, that the possible effects of violation of the assumptions above must be kept in mind when interpreting our results.

Electronic supplementary material

Supplementary information (426.5KB, pdf)
Supplementary Data S1 (40.8KB, xlsx)

Acknowledgements

We thank the vector and parasite surveillance staff of Goiás State Health Department and the Federal District Environmental Surveillance Agency, Brazil. We also thank F. das Chagas, D.A. Rocha, and V.J. de Mendonça for assistance. M.R.F. de Oliveira made useful comments on an earlier draft of the manuscript, and R.N. This work was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, grant 1276/2011) and the Fundação de Amparo à Pesquisa do Distrito Federal (FAP-DF, grant 6098/2013), Brazil. Additional support came from the Instituto René Rachou and the Vice-Presidência de Pesquisa e Laboratórios de Referência (both at Fiocruz, Brazil).

Author Contributions

F.A.-F. and R.G.-G. conceived the project, R.G.-G., C.A.C.C. and N.N. designed the experiments, T.T.C.M.-S., C.S., L.H., M.K., M.S., M.R., N.N. and T.E.V. performed the experiments, and F.A.-F. analysed the data. R.G.-G. and N.N. provided resources, and F.A.-F., R.G.-G. and T.T.C.M.-S. drafted the manuscript and prepared the figures. All authors reviewed and contributed to the final version of the manuscript.

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Fernando Abad-Franch and Rodrigo Gurgel-Gonçalves contributed equally to this work.

A correction to this article is available online at https://doi.org/10.1038/s41598-018-24849-3.

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-017-18532-2.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

5/4/2018

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Contributor Information

Fernando Abad-Franch, Email: fernando.abad@minas.fiocruz.br.

Rodrigo Gurgel-Gonçalves, Email: rgurgel@unb.br.

References

  • 1.Institute of Medicine. Vector-borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections (The National Academies Press, 2008). [PubMed]
  • 2.Gu W, Unnasch TR, Katholi CR, Lampman R, Novak RJ. Fundamental issues in mosquito surveillance for arboviral transmission. Trans. R. Soc. Trop. Med. Hyg. 2008;102:817–822. doi: 10.1016/j.trstmh.2008.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Braks M, et al. Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasit. Vectors. 2011;4:192. doi: 10.1186/1756-3305-4-192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Semenza JC, Zeller H. Integrated surveillance for prevention and control of emerging vector-borne diseases in Europe. Euro Surveill. 2014;19:20757. doi: 10.2807/1560-7917.ES2014.19.13.20757. [DOI] [PubMed] [Google Scholar]
  • 5.Springer YP, et al. Tick-, mosquito-, and rodent-borne parasite sampling designs for the National Ecological ObservatoryNetwork. Ecosphere. 2016;7:e01271. doi: 10.1002/ecs2.1271. [DOI] [Google Scholar]
  • 6.Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin. Infect. Dis. 2009;49:1103–1108. doi: 10.1086/605574. [DOI] [PubMed] [Google Scholar]
  • 7.Banoo S, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat. Rev. Microbiol. 2010;8:S17–S29. [PubMed] [Google Scholar]
  • 8.Institute of Medicine. Global Infectious Disease Surveillance and Detection: Assessing the Challenges—Finding Solutions. Workshop Summary (The National Academies Press, 2007). [PubMed]
  • 9.Drain, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect. Dis. 2014;14:239–249. doi: 10.1016/S1473-3099(13)70250-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ndao M. Diagnosis of parasitic diseases: old and new approaches. Interdiscip. Perspect. Infect. Dis. 2009;2009:278246. doi: 10.1155/2009/278246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng. 2008;10:107–144. doi: 10.1146/annurev.bioeng.10.061807.160524. [DOI] [PubMed] [Google Scholar]
  • 12.Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012;9:e1001306. doi: 10.1371/journal.pmed.1001306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lent H, Wygodzinsky P. Revision of the Triatominae (Hemiptera: Reduviidae) and their significance as vectors of Chagas’ disease. Bull. Am. Mus. Nat. Hist. 1979;163:123–520. [Google Scholar]
  • 14.World Health Organization. Control of Chagas disease. Second report of the WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 905, 1–109 (2002). [PubMed]
  • 15.Abad-Franch F, Vega MC, Rolón MS, Santos WS, Rojas de Arias A. Community participation in Chagas disease vector surveillance: Systematic review. PLoS Negl. Trop. Dis. 2011;5:e1207. doi: 10.1371/journal.pntd.0001207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dias JC, et al. 2nd Brazilian Consensus on Chagas Disease, 2015. Rev. Soc. Bras. Med. Trop. 2016;49(Suppl. 1):3–60. doi: 10.1590/0037-8682-0505-2016. [DOI] [PubMed] [Google Scholar]
  • 17.Brenière SF, et al. Field application of polymerase chain reaction diagnosis and strain typing of Trypanosoma cruzi in Bolivian triatomines. Am. J. Trop. Med. Hyg. 1995;53:179–184. doi: 10.4269/ajtmh.1995.53.179. [DOI] [PubMed] [Google Scholar]
  • 18.Brenière SF, et al. Peridomestic colonization of Triatoma longipennis (Hemiptera, Reduviidae) and Triatoma barberi (Hemiptera, Reduviidae) in a rural community with active transmission of Trypanosoma cruzi in Jalisco state, Mexico. Acta Trop. 2007;101:249–257. doi: 10.1016/j.actatropica.2007.02.007. [DOI] [PubMed] [Google Scholar]
  • 19.Kirchhoff LV, Votava JR, Ochs DE, Moser DR. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J. Clin. Microbiol. 1996;34:1171–1175. doi: 10.1128/jcm.34.5.1171-1175.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Shikanai-Yasuda MA, Ochs DE, Tolezan JE, Kirchhoff LV. Use of the polymerase chain reaction for detecting Trypanosoma cruzi in triatomine vectors. Trans. R. Soc. Trop. Med. Hyg. 1996;90:649–651. doi: 10.1016/S0035-9203(96)90419-8. [DOI] [PubMed] [Google Scholar]
  • 21.Dorn PL, et al. Utility of the polymerase chain reaction in detection of Trypanosoma cruzi in Guatemalan Chagas’ disease vectors. Am. J. Trop. Med. Hyg. 1999;60:740–745. doi: 10.4269/ajtmh.1999.60.740. [DOI] [PubMed] [Google Scholar]
  • 22.Pizarro JC, Lucero DE, Stevens L. PCR reveals significantly higher rates of Trypanosoma cruzi infection than microscopy in the Chagas vector, Triatoma infestans: high rates found in Chuquisaca, Bolivia. BMC Infect. Dis. 2007;7:66. doi: 10.1186/1471-2334-7-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lardeux F, Aliaga C, Depickère S. Bias due to methods of parasite detection when estimating prevalence of infection of Triatoma infestans by Trypanosoma cruzi. J. Vector Ecol. 2016;41:285–291. doi: 10.1111/jvec.12224. [DOI] [PubMed] [Google Scholar]
  • 24.Miller DA, et al. Improving occupancy estimation when two types of observational error occur: non-detection and species misidentification. Ecology. 2011;92:1422–1428. doi: 10.1890/10-1396.1. [DOI] [PubMed] [Google Scholar]
  • 25.Burnham, K.P. & Anderson, D.R. Model Selection and Multimodel Inference: A Practical Information-theoretic Approach. (Springer, 2002).
  • 26.Chen G, Kéry M, Zhang J, Ma K. Factors affecting detection probability in plant distribution studies. J. Ecol. 2009;97:1383–1389. doi: 10.1111/j.1365-2745.2009.01560.x. [DOI] [Google Scholar]
  • 27.Abad-Franch F, et al. Modeling disease vector occurrence when detection is imperfect: infestation of Amazonian palm trees by triatomine bugs at three spatial scales. PLoS Negl. Trop. Dis. 2010;4:e620. doi: 10.1371/journal.pntd.0000620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Abad-Franch F, Valença-Barbosa C, Sarquis O, Lima MM. All that glisters is not gold: sampling-process uncertainty in disease-vector surveys with false-negative and false-positive detections. PLoS Negl. Trop. Dis. 2014;8:e3187. doi: 10.1371/journal.pntd.0003187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kéry M, Gardner B, Monnerat C. Predicting species distributions from checklist data using site-occupancy models. J. Biogeogr. 2010;37:1851–1862. [Google Scholar]
  • 30.Poley LG, et al. Occupancy patterns of large mammals in the Far North of Ontario under imperfect detection and spatial autocorrelation. J. Biogeogr. 2014;41:122–132. doi: 10.1111/jbi.12200. [DOI] [Google Scholar]
  • 31.McClintock BT, et al. Seeking a second opinion: uncertainty in disease ecology. Ecol. Lett. 2010;13:659–674. doi: 10.1111/j.1461-0248.2010.01472.x. [DOI] [PubMed] [Google Scholar]
  • 32.Schmidt BR, Kéry M, Ursenbacher S, Hyman OJ, Collins JP. Site occupancy models in the analysis of environmental DNA presence/absence surveys: a case study of an emerging amphibian pathogen. Methods Ecol. Evol. 2012;4:646–653. doi: 10.1111/2041-210X.12052. [DOI] [Google Scholar]
  • 33.Elmore SA, et al. Toxoplasma gondii exposure in arctic-nesting geese: a multi-state occupancy framework and comparison of serological assays. Int. J. Parasitol. Parasites Wildl. 2014;3:147–153. doi: 10.1016/j.ijppaw.2014.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ochola LB, Vounatsou P, Smith T, Mabaso ML, Newton CR. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect. Dis. 2006;6:582–588. doi: 10.1016/S1473-3099(06)70579-5. [DOI] [PubMed] [Google Scholar]
  • 35.Lachish S, Gopalaswamy AM, Knowles SCL, Sheldon BC. Site-occupancy modelling as a novel framework for assessing test sensitivity and estimating wildlife disease prevalence from imperfect diagnostic tests. Methods Ecol. Evol. 2012;3:339–348. doi: 10.1111/j.2041-210X.2011.00156.x. [DOI] [Google Scholar]
  • 36.Miller DAW, Talley BL, Lips KR, Campbell Grant EH. Estimating patterns and drivers of infection prevalence and intensity when detection is imperfect and sampling error occurs. Methods Ecol. Evol. 2012;3:850–859. doi: 10.1111/j.2041-210X.2012.00216.x. [DOI] [Google Scholar]
  • 37.Cohen J. The Earth is round (p < .05). Am. Psychologist. 1994;49:997–1003. doi: 10.1037/0003-066X.49.12.997. [DOI] [Google Scholar]
  • 38.World Health Organization. Communicable Disease Surveillance and Response Systems. Guide to Monitoring and Evaluating (WHO/CDS/EPR/LYO/2006.2, World Health Organization, 2006).
  • 39.Abad-Franch F, Diotaiuti L, Gurgel-Gonçalves R, Gürtler RE. On bugs and bias: improving Chagas disease control assessment. Mem. Inst. Oswaldo Cruz. 2014;109:125–130. [PubMed] [Google Scholar]
  • 40.Vacek PM. The effect of conditional dependence on the evaluation of diagnostic tests. Biometrics. 1985;41:959–968. doi: 10.2307/2530967. [DOI] [PubMed] [Google Scholar]
  • 41.Toft N, Jørgensen E, Højsgaard S. Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard. Prev. Vet. Med. 2005;68:19–33. doi: 10.1016/j.prevetmed.2005.01.006. [DOI] [PubMed] [Google Scholar]
  • 42.Ramírez JC, et al. Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. J. Mol. Diagn. 2015;17:605–615. doi: 10.1016/j.jmoldx.2015.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Minuzzi-Souza, T. T. C. Detecção Parasitológica e Molecular de Tripanossomatídeos em Triatomíneos Sinantrópicos e Primatas Neotropicais no Brasil Central. (PhD Thesis, University of Brasília, 2016).
  • 44.Coura, J. R. (ed) Manual de Capacitação na Detecção de Trypanosoma cruzi para Microscopistas de Malária e Laboratoristas da Rede Pública (PAHO-WHO/Fiocruz, 2011).
  • 45.Perlowagora-Szumlewicz A, Moreira CJC. In vivo differentiation of Trypanosoma cruzi – 1. Experimental evidence of the influence of vector species on metacyclogenesis. Mem. Inst. Oswaldo Cruz. 1994;89:603–618. doi: 10.1590/S0074-02761994000400018. [DOI] [PubMed] [Google Scholar]
  • 46.Lyman DF, et al. Mitochondrial DNA sequence variation among triatomine vectors of Chagas’ disease. Am. J. Trop. Med. Hyg. 1999;60:377–386. doi: 10.4269/ajtmh.1999.60.377. [DOI] [PubMed] [Google Scholar]
  • 47.Schijman AG, et al. Differential detection of Blastocrithidia triatomae and Trypanosoma cruzi by amplification of 24Sα ribosomal RNA genes in faeces of sylvatic triatomine species from rural northwestern Argentina. Acta Trop. 2006;99:50–54. doi: 10.1016/j.actatropica.2006.06.010. [DOI] [PubMed] [Google Scholar]
  • 48.Ndao M, et al. Trypanosoma cruzi infection of squirrel monkeys: comparison of blood smear examination, commercial enzyme-linked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries. Comp. Med. 2000;50:658–665. [PubMed] [Google Scholar]
  • 49.Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. BioTechniques. 1997;22:130–138. doi: 10.2144/97221bi01. [DOI] [PubMed] [Google Scholar]
  • 50.Rutledge RG, Côté C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res. 2003;31:e93. doi: 10.1093/nar/gng093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Hines, J. E. PRESENCE – Software to estimate patch occupancy and related parameters, v. 11.8. USGS – PWRC. www.mbr-pwrc.usgs.gov/software/presence.html. (2006)
  • 52.Cuba Cuba CA. Revisión de los aspectos biológicos y diagnósticos del Trypanosoma (Herpetosoma) rangeli. Rev. Soc. Bras. Med. Trop. 1998;31:207–220. doi: 10.1590/S0037-86821998000200007. [DOI] [PubMed] [Google Scholar]
  • 53.de Sousa MA. Morphobiological characterization of Trypanosoma cruzi Chagas, 1909 and its distinction from other trypanosomes. Mem. Inst. Oswaldo Cruz. 1999;94:205–210. doi: 10.1590/S0074-02761999000700031. [DOI] [PubMed] [Google Scholar]
  • 54.Schaub, G. A. Interactions of trypanosomatids and triatomines in Advances in Insect Physiology, vol. 37 (ed. Simpson, J.S., Casas, J.) 177–242 (Academic Press, 2009).

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information (426.5KB, pdf)
Supplementary Data S1 (40.8KB, xlsx)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES